David A. Siegel Innoviva, Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Innoviva, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 406,100 shares of INVA stock, worth $6.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
406,100
Previous 211,000
92.46%
Holding current value
$6.66 Million
Previous $3.38 Million
82.86%
% of portfolio
0.01%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding INVA
# of Institutions
220Shares Held
78.8MCall Options Held
45.9KPut Options Held
14.1K-
Black Rock Inc. New York, NY10.1MShares$166 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$119 Million19.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.29MShares$103 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA6.27MShares$103 Million0.03% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$103 Million0.14% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.14B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...